A cell-based bioluminescence assay reveals dose-dependent and contextual repression of AP-1-driven gene expression by BACH2.

A cell-based bioluminescence assay reveals dose-dependent and contextual repression of AP-1-driven gene expression by BACH2.
复制标题

DOI:
10.1038/s41598-020-75732-z
复制
发表时间:
2020-11-03
期刊:
影响因子:
4.6
通讯作者:
Roychoudhuri R
Roychoudhuri R
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Vardaka P;Lozano T;Bot C;Ellery J;Whiteside SK;Imianowski CJ;Farrow S;Walker S;Okkenhaug H;Yang J;Okkenhaug K;Kuo P;Roychoudhuri R

文献摘要

参考文献

相似文献

尽管效应CD 4+和CD 8 + T细胞促进免疫活化并可驱动感染和癌症的清除,但CD 4+调节性T(Treg)细胞抑制其功能,有助于免疫稳态和癌症免疫抑制。转录因子BACH 2作为T细胞分化的普遍调节剂发挥作用,促进CD 4 + Treg细胞的发育并抑制多效应T细胞(Teff)谱系的效应子功能。在这里,我们报告了一个稳定的基于细胞的生物发光测定BACH 2的转录因子活性的发展。四环素诱导的BACH 2表达导致抑制佛波醇12-肉豆蔻酸酯13-乙酸酯(PMA)/离子霉素驱动的荧光素酶报告基因的激活,该报告基因含有来自小鼠Ifng +18 k增强子的BACH 2/AP-1靶序列。BACH 2表达以剂量依赖性方式抑制荧光素酶信号,但在高水平AP-1信号传导时这种活性被消除,表明BACH 2对AP-1驱动的基因表达的背景调节。最后,使用开发的报告分析,我们发现,组蛋白脱乙酰酶3(HDAC 3)的选择性抑制剂,RGFP 966,抑制BACH 2介导的信号驱动的荧光素酶表达的抑制。除了能够进行机制研究之外,这种基于细胞的报告基因还可以鉴定BACH 2功能的小分子激动剂或拮抗剂,用于药物开发。
Whereas effector CD4+ and CD8+ T cells promote immune activation and can drive clearance of infections and cancer, CD4+ regulatory T (Treg) cells suppress their function, contributing to both immune homeostasis and cancer immunosuppression. The transcription factor BACH2 functions as a pervasive regulator of T cell differentiation, promoting development of CD4+ Treg cells and suppressing the effector functions of multiple effector T cell (Teff) lineages. Here, we report the development of a stable cell-based bioluminescence assay of the transcription factor activity of BACH2. Tetracycline-inducible BACH2 expression resulted in suppression of phorbol 12-myristate 13-acetate (PMA)/ionomycin-driven activation of a luciferase reporter containing BACH2/AP-1 target sequences from the mouse Ifng + 18k enhancer. BACH2 expression repressed the luciferase signal in a dose-dependent manner but this activity was abolished at high levels of AP-1 signalling, suggesting contextual regulation of AP-1 driven gene expression by BACH2. Finally, using the reporter assay developed, we find that the histone deacetylase 3 (HDAC3)-selective inhibitor, RGFP966, inhibits BACH2-mediated repression of signal-driven luciferase expression. In addition to enabling mechanistic studies, this cell-based reporter may enable identification of small molecule agonists or antagonists of BACH2 function for drug development.
DOI: 10.1016/j.sigpro.2009.07.009
发表时间: 2010-02-01
期刊: SIGNAL PROCESSING
影响因子: 4.4
作者:
Luisier, Florian;Vonesch, Cedric;Unser, Michael
通讯作者: Unser, Michael
DOI: 10.1126/science.1233465
发表时间: 2013-05-10
期刊: Science (New York, N.Y.)
影响因子: --
作者:
Reinke AW;Baek J;Ashenberg O;Keating AE
通讯作者: Keating AE
DOI: 10.1126/science.2494701
发表时间: 1989-03-31
期刊: SCIENCE
影响因子: 56.9
作者:
TURNER, R;TJIAN, R
通讯作者: TJIAN, R
DOI: 10.1038/ncomms12596
发表时间: 2016-09-01
影响因子: 16.6
作者:
Kuwahara, Makoto;Ise, Wataru;Ochi, Mizuki;Suzuki, Junpei;Kometani, Kohei;Maruyama, Saho;Izumoto, Maya;Matsumoto, Akira;Takemori, Nobuaki;Takemori, Ayako;Shinoda, Kenta;Nakayama, Toshinori;Ohara, Osamu;Yasukawa, Masaki;Sawasaki, Tatsuya;Kurosaki, Tomohiro;Yamashita, Masakatsu
通讯作者: Yamashita, Masakatsu
DOI: 10.1146/annurev.immunol.25.022106.141623
发表时间: 2012
影响因子: 29.7
作者:
Josefowicz SZ;Lu LF;Rudensky AY
通讯作者: Rudensky AY